257 related articles for article (PubMed ID: 2140395)
1. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity.
Rosenblum MG; Yung WK; Kelleher PJ; Ruzicka F; Steck PA; Borden EC
J Interferon Res; 1990 Apr; 10(2):141-51. PubMed ID: 2140395
[TBL] [Abstract][Full Text] [Related]
2. Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro.
Ruzicka FJ; Schmid SM; Groveman DS; Cummings KB; Borden EC
Cancer Res; 1987 Sep; 47(17):4582-9. PubMed ID: 2957045
[TBL] [Abstract][Full Text] [Related]
3. Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.
Schiller JH; Horisberger MA; Bittner G; Carlin JM; Storer B; Byrne GI; Willson JK; Borden EC
J Biol Response Mod; 1990 Aug; 9(4):368-77. PubMed ID: 2395002
[TBL] [Abstract][Full Text] [Related]
4. Binding of human recombinant 125I-interferon gamma to receptors on human cells.
Littman SJ; Faltynek CR; Baglioni C
J Biol Chem; 1985 Jan; 260(2):1191-5. PubMed ID: 3155725
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of 2',5'-oligoadenylate synthetase by IFN-beta ser and IFN-alpha 2 in serum-supplemented and serum-free HL-60 leukemic cell cultures.
Fraioli M; Wu JM
J Biol Regul Homeost Agents; 1989; 3(3):112-7. PubMed ID: 2624146
[TBL] [Abstract][Full Text] [Related]
6. Differential activity of the 30-kD and the 100-kD forms of 2'-5'An synthetase induced by recombinant human interferon-alpha and interferon-gamma.
Rosenblum MG; Cheung L; Kessler D
J Interferon Res; 1988 Jun; 8(3):275-82. PubMed ID: 3137274
[TBL] [Abstract][Full Text] [Related]
7. Lectins modulate the internalization of recombinant interferon-alpha A and the induction of 2',5'-oligo(A) synthetase.
Faltynek CR; Princler GL; Ruscetti FW; Birchenall-Sparks M
J Biol Chem; 1988 May; 263(15):7112-7. PubMed ID: 2966801
[TBL] [Abstract][Full Text] [Related]
8. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibitory effect of recombinant alpha and beta interferon on human glioma cells.
Yung WK; Steck PA; Kelleher PJ; Moser RP; Rosenblum MG
J Neurooncol; 1987; 5(4):323-30. PubMed ID: 2964515
[TBL] [Abstract][Full Text] [Related]
10. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.
Schiller JH; Bushmeyer SM; Ruzicka FJ; Princler GL; Faltynek CR; Borden EC
Cancer Res; 1990 Jan; 50(1):26-31. PubMed ID: 2136700
[TBL] [Abstract][Full Text] [Related]
11. Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta.
Yoshida R; Murray HW; Nathan CF
J Exp Med; 1988 Mar; 167(3):1171-85. PubMed ID: 2965208
[TBL] [Abstract][Full Text] [Related]
12. A functional protein kinase C is required for induction of 2-5A synthetase by recombinant interferon-alpha A in Daudi cells.
Faltynek CR; Princler GL; Gusella GL; Varesio L; Radzioch D
J Biol Chem; 1989 Aug; 264(24):14305-11. PubMed ID: 2474543
[TBL] [Abstract][Full Text] [Related]
13. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
[TBL] [Abstract][Full Text] [Related]
14. Binding of unglycosylated and glycosylated human recombinant interferon-gamma to cellular receptors.
Littman SJ; Devos R; Baglioni C
J Interferon Res; 1985; 5(3):471-6. PubMed ID: 2932505
[TBL] [Abstract][Full Text] [Related]
15. Binding of recombinant-produced interferon beta ser to human lymphoblastoid cells. Evidence for two binding domains.
Ruzicka FJ; Jach ME; Borden EC
J Biol Chem; 1987 Nov; 262(33):16142-9. PubMed ID: 2960673
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II trial of interferon-beta-serine in patients with renal cell carcinoma: immunological and biological effects.
Rinehart JJ; Young D; Laforge J; Colborn D; Neidhart JA
Cancer Res; 1987 May; 47(9):2481-5. PubMed ID: 3567933
[TBL] [Abstract][Full Text] [Related]
17. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the human type I interferon receptor by ligand blotting.
Schwabe M; Princler GL; Faltynek CR
Eur J Immunol; 1988 Dec; 18(12):2009-14. PubMed ID: 2975600
[TBL] [Abstract][Full Text] [Related]
19. Effects of type I and II interferons on cultured human breast cells: interaction with estrogen receptors and with tamoxifen.
Goldstein D; Bushmeyer SM; Witt PL; Jordan VC; Borden EC
Cancer Res; 1989 May; 49(10):2698-702. PubMed ID: 2469536
[TBL] [Abstract][Full Text] [Related]
20. Interferons-alpha/beta- and -gamma-resistant Friend cell variants exhibiting receptor sites for interferons but no induction of 2-5A synthetase and 67K protein kinase.
Coccia EM; Federico M; Romeo G; Affabris E; Cofano F; Rossi GB
J Interferon Res; 1988 Feb; 8(1):113-27. PubMed ID: 2966842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
